American Renal Associates (ARA) is Initiated by Goldman to Neutral

American Renal Associates (ARA) was Initiated by Goldman to “Neutral”. Goldman advised their investors in a research report released on May 16, 2016.

In a different news, on Apr 27, 2016, Syed T Kamal (PRESIDENT) purchased 500 shares at $22.00 per share price. According to the SEC, on Apr 27, 2016, Michael Ray Costa (VP, GC AND SECRETARY) purchased 370 shares at $22.00 per share price. On Apr 27, 2016, Joseph A Carlucci (CEO) purchased 500 shares at $22.00 per share price, according to the Form-4 filing with the securities and exchange commission.

American Renal Associates

Leave a Reply

American Renal Associates - Is it time to Sell?

Top Brokerage Firms are advising their investors on American Renal Associates. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.